Using response surface models to analyze drug combinations

Quantitative evaluation of how drugs combine to elicit a biological response is crucial for drug development. Evaluations of drug combinations are often performed using index-based methods, which are known to be biased and unstable. We examine how these methods can produce misleadingly structured patterns of bias, leading to erroneous judgments of synergy or antagonism. By contrast, response surface models are less prone to these defects and can be applied to a wide range of data that have appeared in recent literature, including the measurement of combination therapeutic windows and the analysis of discrete experimental measures, three-way drug combinations, and atypical response behaviors.

Automated summary

The quantitative evaluation of drug combinations is crucial for drug development. Index-based methods are known to be biased and unstable, whereas response surface models are less prone to these defects and can be applied to a wide range of data.